These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32856318)

  • 1. PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG Changes.
    Shi X; Lim Y; Myers AK; Stallings BL; Mccoy A; Zeiger J; Scheck J; Cho G; Marsh ED; Mirzaa GM; Tao T; Golden JA
    Ann Neurol; 2020 Dec; 88(6):1077-1094. PubMed ID: 32856318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
    Rivière JB; Mirzaa GM; O'Roak BJ; Beddaoui M; Alcantara D; Conway RL; St-Onge J; Schwartzentruber JA; Gripp KW; Nikkel SM; Worthylake T; Sullivan CT; Ward TR; Butler HE; Kramer NA; Albrecht B; Armour CM; Armstrong L; Caluseriu O; Cytrynbaum C; Drolet BA; Innes AM; Lauzon JL; Lin AE; Mancini GM; Meschino WS; Reggin JD; Saggar AK; Lerman-Sagie T; Uyanik G; Weksberg R; Zirn B; Beaulieu CL; ; Majewski J; Bulman DE; O'Driscoll M; Shendure J; Graham JM; Boycott KM; Dobyns WB
    Nat Genet; 2012 Jun; 44(8):934-40. PubMed ID: 22729224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.
    Mirzaa GM; Rivière JB; Dobyns WB
    Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):122-30. PubMed ID: 23592320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study.
    Mirzaa GM; Conti V; Timms AE; Smyser CD; Ahmed S; Carter M; Barnett S; Hufnagel RB; Goldstein A; Narumi-Kishimoto Y; Olds C; Collins S; Johnston K; Deleuze JF; Nitschké P; Friend K; Harris C; Goetsch A; Martin B; Boyle EA; Parrini E; Mei D; Tattini L; Slavotinek A; Blair E; Barnett C; Shendure J; Chelly J; Dobyns WB; Guerrini R
    Lancet Neurol; 2015 Dec; 14(12):1182-95. PubMed ID: 26520804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.
    Tapper WJ; Foulds N; Cross NC; Aranaz P; Score J; Hidalgo-Curtis C; Robinson DO; Gibson J; Ennis S; Temple IK; Collins A
    PLoS One; 2014; 9(1):e86940. PubMed ID: 24497998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
    Mirzaa G; Parry DA; Fry AE; Giamanco KA; Schwartzentruber J; Vanstone M; Logan CV; Roberts N; Johnson CA; Singh S; Kholmanskikh SS; Adams C; Hodge RD; Hevner RF; Bonthron DT; Braun KPJ; Faivre L; Rivière JB; St-Onge J; Gripp KW; Mancini GM; Pang K; Sweeney E; van Esch H; Verbeek N; Wieczorek D; Steinraths M; Majewski J; ; Boycot KM; Pilz DT; Ross ME; Dobyns WB; Sheridan EG
    Nat Genet; 2014 May; 46(5):510-515. PubMed ID: 24705253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy.
    Roy A; Skibo J; Kalume F; Ni J; Rankin S; Lu Y; Dobyns WB; Mills GB; Zhao JJ; Baker SJ; Millen KJ
    Elife; 2015 Dec; 4():. PubMed ID: 26633882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH.
    Nakamura K; Kato M; Tohyama J; Shiohama T; Hayasaka K; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Matsumoto N; Saitsu H
    Clin Genet; 2014 Apr; 85(4):396-8. PubMed ID: 23745724
    [No Abstract]   [Full Text] [Related]  

  • 9. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.
    Jansen LA; Mirzaa GM; Ishak GE; O'Roak BJ; Hiatt JB; Roden WH; Gunter SA; Christian SL; Collins S; Adams C; Rivière JB; St-Onge J; Ojemann JG; Shendure J; Hevner RF; Dobyns WB
    Brain; 2015 Jun; 138(Pt 6):1613-28. PubMed ID: 25722288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.
    Negishi Y; Miya F; Hattori A; Johmura Y; Nakagawa M; Ando N; Hori I; Togawa T; Aoyama K; Ohashi K; Fukumura S; Mizuno S; Umemura A; Kishimoto Y; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Nakanishi M; Saitoh S
    BMC Med Genet; 2017 Jan; 18(1):4. PubMed ID: 28086757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.
    Alcantara D; Timms AE; Gripp K; Baker L; Park K; Collins S; Cheng C; Stewart F; Mehta SG; Saggar A; Sztriha L; Zombor M; Caluseriu O; Mesterman R; Van Allen MI; Jacquinet A; Ygberg S; Bernstein JA; Wenger AM; Guturu H; Bejerano G; Gomez-Ospina N; Lehman A; Alfei E; Pantaleoni C; Conti V; Guerrini R; Moog U; Graham JM; Hevner R; Dobyns WB; O'Driscoll M; Mirzaa GM
    Brain; 2017 Oct; 140(10):2610-2622. PubMed ID: 28969385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR.
    Dobyns WB; Mirzaa GM
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):582-590. PubMed ID: 31441589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia.
    Terrone G; Voisin N; Abdullah Alfaiz A; Cappuccio G; Vitiello G; Guex N; D'Amico A; James Barkovich A; Brunetti-Pierri N; Del Giudice E; Reymond A
    Eur J Hum Genet; 2016 Aug; 24(9):1359-62. PubMed ID: 26860062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal mosaicism underlies the inheritance of a rare germline AKT3 variant which is responsible for megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome in two Roma half-siblings.
    Szalai R; Melegh BI; Till A; Ripszam R; Csabi G; Acharya A; Schrauwen I; Leal SM; Komoly S; Kosztolanyi G; Hadzsiev K
    Exp Mol Pathol; 2020 Aug; 115():104471. PubMed ID: 32446860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymicrogyria in association with hypoglycemia points to mutation in the mTOR pathway.
    Stutterd C; McGillivray G; Stark Z; Messazos B; Cameron F; White S; ; Mirzaa G; Leventer R
    Eur J Med Genet; 2018 Dec; 61(12):738-740. PubMed ID: 29883676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Characterization of a Novel Constitutional PIK3CA Mutation in a Child Lacking the Typical Segmental Overgrowth of "PIK3CA-Related Overgrowth Spectrum".
    Di Donato N; Rump A; Mirzaa GM; Alcantara D; Oliver A; Schrock E; Dobyns WB; O'Driscoll M
    Hum Mutat; 2016 Mar; 37(3):242-5. PubMed ID: 26593112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.
    Pirozzi F; Lee B; Horsley N; Burkardt DD; Dobyns WB; Graham JM; Dentici ML; Cesario C; Schallner J; Porrmann J; Di Donato N; Sanchez-Lara PA; Mirzaa GM
    Am J Med Genet A; 2021 Sep; 185(9):2719-2738. PubMed ID: 34087052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Zhao MF; Zhang SL; Xiang Y; Wang Q; Cao GH; Zhang PP; Fan LL; Yu R; Li YL
    DNA Cell Biol; 2024 Jul; 43(7):325-330. PubMed ID: 38700464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain overgrowth in disorders of RTK-PI3K-AKT signaling: a mosaic of malformations.
    Hevner RF
    Semin Perinatol; 2015 Feb; 39(1):36-43. PubMed ID: 25432429
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.